NASDAQ:SYNH - Syneos Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $68.00
  • Forecasted Upside: 17.12 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$58.06
▼ -0.18 (-0.31%)
1 month | 3 months | 12 months
Get New Syneos Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SYNH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SYNH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$68.00
▲ +17.12% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Syneos Health in the last 3 months. The average price target is $68.00, with a high forecast of $82.00 and a low forecast of $52.00. The average price target represents a 17.12% upside from the last price of $58.06.
Buy
The current consensus among 12 investment analysts is to buy stock in Syneos Health.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/3/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/1/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/6/2020MizuhoUpgradeNeutral ➝ Buy$63.00 ➝ $65.00Low
i
10/1/2020Goldman Sachs GroupUpgradeNeutral ➝ Buy$69.00 ➝ $75.00High
i
8/12/2020Truist FinancialBoost Price TargetBuy$74.00 ➝ $80.00Medium
i
8/7/2020CitigroupBoost Price TargetBuy$70.00 ➝ $75.00Low
i
8/7/2020MizuhoBoost Price TargetNeutral$50.00 ➝ $63.00Low
i
7/16/2020SunTrust BanksBoost Price TargetBuy$66.00 ➝ $74.00Low
i
5/1/2020SunTrust BanksBoost Price TargetBuy$56.00 ➝ $66.00Medium
i
4/30/2020CfraBoost Price TargetBuy$55.00 ➝ $61.00Medium
i
4/28/2020UBS GroupLower Price TargetNeutral$74.00 ➝ $58.00High
i
4/9/2020CitigroupLower Price TargetBuy$85.00 ➝ $65.00High
i
4/3/2020MizuhoLower Price TargetNeutral$56.00 ➝ $42.00Medium
i
4/2/2020Credit Suisse GroupLower Price TargetOutperform$72.00 ➝ $62.00High
i
Rating by Erin Wright at Credit Suisse Group AG
3/30/2020Goldman Sachs GroupDowngradeBuy ➝ Neutral$79.00 ➝ $45.00High
i
3/26/2020BarclaysLower Price TargetEqual Weight$67.00 ➝ $61.00Medium
i
3/23/2020Jefferies Financial GroupLower Price TargetBuy$80.00 ➝ $52.00Medium
i
Rating by David Windley at Jefferies Financial Group Inc.
3/17/2020SunTrust BanksLower Price TargetBuy$80.00 ➝ $58.00Low
i
2/23/2020BarclaysReiterated RatingHold$67.00High
i
2/21/2020Credit Suisse GroupBoost Price TargetOutperform$68.00 ➝ $72.00Low
i
Rating by Erin Wright at Credit Suisse Group AG
2/21/2020Robert W. BairdBoost Price TargetOutperform$74.00 ➝ $82.00Low
i
2/21/2020UBS GroupBoost Price TargetNeutral$62.00 ➝ $74.00Low
i
2/21/2020MizuhoBoost Price TargetNeutral$52.00 ➝ $67.00Low
i
1/21/2020Credit Suisse GroupReiterated RatingBuy$68.00Low
i
Rating by Erin Wright at Credit Suisse Group AG
1/16/2020Robert W. BairdBoost Price TargetOutperform$62.00 ➝ $74.00Medium
i
1/16/2020KeyCorpBoost Price TargetOverweight$65.00 ➝ $71.00Medium
i
1/6/2020CitigroupInitiated CoverageBuy$75.00Low
i
9/23/2019Jefferies Financial GroupBoost Price TargetBuy$62.00 ➝ $65.00Low
i
9/3/2019KeyCorpBoost Price TargetOverweight$63.00 ➝ $65.00Low
i
8/29/2019UBS GroupBoost Price TargetNeutral$53.50 ➝ $57.00Low
i
Rating by Daniel Brennan at UBS Group AG
8/23/2019Credit Suisse GroupBoost Price TargetOutperform$56.00 ➝ $58.00High
i
8/8/2019KeyCorpBoost Price TargetOverweight$59.00 ➝ $63.00Low
i
8/7/2019SunTrust BanksBoost Price TargetBuy$68.00Low
i
4/17/2019BarclaysReiterated RatingHold$48.00High
i
4/2/2019Wolfe ResearchInitiated CoverageMarket PerformMedium
i
3/19/2019UBS GroupDowngradeBuy ➝ Neutral$55.00Low
i
Rating by Daniel Brennan at UBS Group AG
3/19/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$49.00 ➝ $51.00Low
i
3/19/2019William BlairReiterated RatingOutperformMedium
i
Rating by J. Kreger at William Blair
1/8/2019Robert W. BairdSet Price TargetBuy$60.00Low
i
Rating by Eric Coldwell at Robert W. Baird
1/3/2019BarclaysLower Price TargetEqual Weight ➝ Equal Weight$51.00 ➝ $45.00Low
i
12/19/2018SunTrust BanksLower Price TargetBuy$55.00Low
i
10/19/2018William BlairUpgradeMarket Perform ➝ OutperformLow
i
Rating by J. Kreger at William Blair
10/9/2018UBS GroupInitiated CoverageBuy ➝ Buy$60.00Low
i
10/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$58.00High
i
8/10/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$54.00 ➝ $59.00Low
i
8/6/2018MizuhoReiterated RatingHold$51.00High
i
8/3/2018SunTrust BanksReiterated RatingBuy$60.00Low
i
8/3/2018BarclaysReiterated RatingEqual Weight ➝ Hold$43.00 ➝ $51.00Medium
i
4/20/2018Mitsubishi UFJ Financial GroupInitiated CoverageOverweight$50.00Low
i
Rating by J. Twizell at Mitsubishi UFJ Financial Group
3/1/2018BarclaysReiterated RatingEqual Weight ➝ Equal Weight$40.00 ➝ $43.00Low
i
3/1/2018SunTrust BanksBoost Price TargetBuy$55.00Low
i
2/26/2018KeyCorpReiterated RatingOverweight ➝ Overweight$50.00 ➝ $46.00Low
i
2/23/2018Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformHigh
i
2/22/2018Robert W. BairdSet Price TargetBuy$50.00High
i
Rating by Eric Coldwell at Robert W. Baird
1/4/2018Credit Suisse GroupReiterated RatingBuy$52.00Medium
i
1/4/2018KeyCorpReiterated RatingBuy$50.00Medium
i
12/11/2017BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$40.00High
i
12/1/2017SunTrust BanksLower Price TargetBuy$50.00Medium
i
12/1/2017MizuhoSet Price TargetNeutral ➝ Neutral$57.00 ➝ $41.00Medium
i
Rating by Ann Hynes at Mizuho
11/16/2017Robert W. BairdSet Price TargetBuy$46.00N/A
i
Rating by Eric Coldwell at Robert W. Baird
11/14/2017Credit Suisse GroupLower Price TargetOutperform$68.00 ➝ $54.00N/A
i
11/13/2017KeyCorpReiterated RatingOverweight ➝ Market Perform$68.00 ➝ $46.00N/A
i
11/10/2017Jefferies Financial GroupReiterated RatingBuy$55.00N/A
i
11/10/2017Robert W. BairdDowngradeOutperform$67.00 ➝ $46.00N/A
i
10/11/2017Credit Suisse GroupInitiated CoverageOutperform$68.00N/A
i
10/9/2017Jefferies Financial GroupUpgradeHold ➝ Buy$62.50 ➝ $69.00N/A
i
10/9/2017Robert W. BairdReiterated RatingBuy$67.00N/A
i
9/21/2017MizuhoInitiated CoverageNeutral$57.00Low
i
8/7/2017Goldman Sachs GroupReiterated RatingBuy ➝ Buy$65.00Low
i
7/30/2017Jefferies Financial GroupReiterated RatingHold$62.50Low
i
6/29/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$62.00 ➝ $64.00High
i
6/20/2017William BlairDowngradeOutperform ➝ Market PerformHigh
i
Rating by J. Kreger at William Blair
6/16/2017Jefferies Financial GroupReiterated RatingBuy$62.00Low
i
6/5/2017KeyCorpUpgradeSector Weight ➝ Overweight$68.00Low
i
5/31/2017SunTrust BanksUpgradeHold ➝ Buy$48.00 ➝ $67.00Medium
i
5/11/2017Jefferies Financial GroupReiterated RatingBuyMedium
i
5/11/2017Robert W. BairdUpgradeNeutral ➝ Outperform$46.00 ➝ $66.00Medium
i
5/3/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformHigh
i
4/21/2017Jefferies Financial GroupReiterated RatingBuy$51.00Low
i
3/20/2017SunTrust BanksDowngradeBuy ➝ Hold$48.00Medium
i
3/1/2017William BlairReiterated RatingOutperformN/A
i
3/1/2017Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy$51.00N/A
i
2/28/2017Jefferies Financial GroupReiterated RatingBuy$59.00 ➝ $51.00N/A
i
1/24/2017Jefferies Financial GroupBoost Price TargetBuy$56.00 ➝ $59.00N/A
i
12/19/2016First AnalysisInitiated CoverageEqual ➝ Equal Weight$59.00N/A
i
11/1/2016Jefferies Financial GroupReiterated RatingBuy$56.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
9/8/2016Goldman Sachs GroupReiterated RatingConviction-Buy$82.00N/A
i
8/17/2016Jefferies Financial GroupLower Price TargetBuy$56.00 ➝ $55.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
8/12/2016Goldman Sachs GroupBoost Price TargetBuy ➝ Buy$60.00 ➝ $62.00N/A
i
6/20/2016Credit Suisse GroupInitiated CoverageOutperform$51.00N/A
i
6/10/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by David Windley at Jefferies Financial Group Inc.
5/22/2016KeyCorpReiterated RatingHoldN/A
i
Rating by Donald Hooker at KeyCorp
5/3/2016Robert W. BairdDowngradeOutperform ➝ Neutral$55.00 ➝ $51.00N/A
i
Rating by Eric Coldwell at Robert W. Baird
4/19/2016Robert W. BairdReiterated RatingBuyN/A
i
Rating by Eric Coldwell at Robert W. Baird
4/18/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by David Windley at Jefferies Financial Group Inc.
4/18/2016Avondale PartnersBoost Price TargetMarket Perform$39.00 ➝ $47.00N/A
i
3/24/2016JPMorgan Chase & Co.Initiated CoverageOverweight$47.00N/A
i
2/26/2016Jefferies Financial GroupLower Price TargetBuy$53.00 ➝ $50.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
12/8/2015Jefferies Financial GroupBoost Price TargetBuy$53.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
11/19/2015SunTrust BanksInitiated CoverageBuy$56.00N/A
i
(Data available from 10/24/2015 forward)
Syneos Health logo
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More

Today's Range

Now: $58.06
$57.31
$59.76

50 Day Range

MA: $57.29
$51.29
$61.56

52 Week Range

Now: $58.06
$30.02
$74.25

Volume

341,911 shs

Average Volume

855,037 shs

Market Capitalization

$6.07 billion

P/E Ratio

32.62

Dividend Yield

N/A

Beta

1.74